SCHEMBL17030719

SCHEMBL17030719

c1ccc(-n2c(-c3ccccc3-n3c4ccccc4c4ccccc43)nnc2-c2ccccc2-n2c3ccccc3c3ccccc32)cc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.55
ATM Q13315 1/20 0.55
L3MBTL1 Q9Y468 1/20 0.55
ALDH1A1 P00352 5/20 0.44
KMT2A Q03164 4/20 0.41
TSHR P16473 2/20 0.41
MEN1 O00255 2/20 0.41
HPGD P15428 2/20 0.40
HTT P42858 2/20 0.39
MAPK8 P45983 2/20 0.39
AKT1 P31749 1/20 0.39
NPC1 O15118 1/20 0.39
LMNA P02545 1/20 0.39
NTRK1 P04629 1/20 0.39
ALOX5 P09917 1/20 0.39
MAPT P10636 1/20 0.39
IDO1 P14902 1/20 0.39
PTGS2 P35354 1/20 0.39
TDO2 P48775 1/20 0.39
RAB9A P51151 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10111060 0.94 KDM4E (0.49) KDM4EATML3MBTL1ALDH1A1TSHR
SCHEMBL17030716 0.89 KDM4E (0.44) KDM4EATML3MBTL1ALDH1A1KMT2A
SCHEMBL10111055 0.85 KDM4E (0.46) KDM4EATML3MBTL1ALDH1A1TSHR
SCHEMBL19732861 0.84 KDM4E (0.41) KDM4EATML3MBTL1ALDH1A1KMT2A
SCHEMBL18932081 0.81 RECQL (0.58) KDM4EATML3MBTL1ALDH1A1KMT2A
SCHEMBL28453269 0.81 L3MBTL1 (0.67) KDM4EATML3MBTL1ALDH1A1KMT2A
SCHEMBL10111054 0.80 KDM4E (0.47) KDM4EATML3MBTL1ALDH1A1KMT2A
SCHEMBL13133990 0.79 KDM4E (0.43) KDM4EATML3MBTL1ALDH1A1KMT2A
SCHEMBL18119531 0.79 KDM4E (0.53) KDM4EATML3MBTL1ALDH1A1KMT2A
SCHEMBL17030715 0.78 KDM4E (0.49) KDM4EATML3MBTL1ALDH1A1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170365790-A1 CARBAZOLE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT DEVICE INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE (TW) 2017-12-21 US disclosed
US-20170365790-A1 CARBAZOLE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT DEVICE INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE (TW) 2017-12-21 US disclosed
US-20160087227-A1 ORGANIC LIGHT-EMITTING DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2016-03-24 US disclosed
US-20160087227-A1 ORGANIC LIGHT-EMITTING DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2016-03-24 US disclosed
US-20150243902-A1 CARBAZOLE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT DEVICE INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE (TW) 2015-08-27 US disclosed
US-20150243902-A1 CARBAZOLE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT DEVICE INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE (TW) 2015-08-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170365790-A1 CARBAZOLE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT DEVICE CYP2C9, CYP2C19, INTS9 KDM4E 2376/4885ATM 2967/4885L3MBTL1 3089/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.